Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Sexually Transmitted Diseases

  Free Subscription


Articles published in J Infect Dis

Retrieve available abstracts of 52 articles:
HTML format
Text format



Single Articles


    December 2016
  1. FLORES-DIAZ E, Sereday KA, Ferreira S, Sirak B, et al
    HPV-6 molecular variants association with the development of genital warts in men: The HIM Study.
    J Infect Dis. 2016 Dec 23. pii: jiw600. doi: 10.1093.
    PubMed     Text format     Abstract available


  2. DONKEN R, Schurink-van 't Klooster TM, Schepp RM, van der Klis FR, et al
    Immune responses after two- versus three-doses of HPV vaccination up to 4(1/2) years post vaccination: an observational study among Dutch routinely vaccinated girls (HPV2D).
    J Infect Dis. 2016 Dec 23. pii: jiw588. doi: 10.1093.
    PubMed     Text format     Abstract available


  3. HEARD I, Tondeur L, Arowas L, Demazoin M, et al
    Effectiveness of HPV vaccination on prevalence of vaccine genotypes in young sexually active women in France.
    J Infect Dis. 2016 Dec 23. pii: jiw639. doi: 10.1093.
    PubMed     Text format     Abstract available


    October 2016
  4. SCHLECHT NF, Diaz A, Shankar V, Szporn AH, et al
    RISK OF DELAYED HPV VACCINATION IN INNER-CITY ADOLESCENT WOMEN.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  5. RUSSELL AN, Zheng X, O'Connell CM, Wiesenfeld HC, et al
    Identification of Chlamydia trachomatis antigens recognized by T cells from highly exposed women who limit or resist genital tract infection.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    September 2016
  6. GRAD YH, Harris SR, Kirkcaldy RD, Green AG, et al
    Genomic epidemiology of gonococcal resistance to extended spectrum cephalosporins, macrolides, and fluoroquinolones in the US, 2000-2013.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    August 2016
  7. REIMERS LL, Mehta SD, Massad LS, Burk RD, et al
    The Cervicovaginal Microbiota and Its Associations with Human Papillomavirus (HPV) Detection in HIV-Infected and HIV-Uninfected Women.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  8. PINTO LA, Kemp TJ, Torres BN, Isaacs K, et al
    THE QUADRIVALENT HPV VACCINE INDUCES HPV-SPECIFIC ANTIBODIES AT THE ORAL CAVITY: RESULTS FROM THE MID-ADULT MALE VACCINE TRIAL-THE MAM TRIAL.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  9. PAMNANI SJ, Nyitray AG, Abrahamsen M, Rollison DE, et al
    Sequential acquisition of anal HPV infection following genital infection among men who have sex with women: the HPV Infection in Men (HIM) Study.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    June 2016
  10. MEITES E, Gorbach PM, Gratzer B, Panicker G, et al
    Monitoring for HPV Vaccine Impact among Gay, Bisexual and other Men who have Sex with Men - United States, 2012-2014.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  11. PRICE MJ, Ades AE, Welton NJ, Simms I, et al
    Proportion of Pelvic Inflammatory Disease Cases Caused by Chlamydia trachomatis: Consistent Picture From Different Methods.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  12. TOTA JE, Ramanakumar AV, Villa LL, Richardson H, et al
    Cervical Infection with Vaccine Human Papillomavirus (HPV) Genotypes as a Predictor of Acquisition and Clearance of Other HPV Infections.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    May 2016
  13. LAPRISE JF, Markowitz LE, Chesson HW, Drolet M, et al
    COMPARING 2- AND 3-DOSE 9-VALENT HPV VACCINE SCHEDULES IN THE U.S.: A COST-EFFECTIVENESS ANALYSIS.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    March 2016
  14. GRAVITT PE, Marks M, Kosek M, Huang C, et al
    Soil-Transmitted Helminth Infections Are Associated With an Increase in Human Papillomavirus Prevalence and a T-Helper Type 2 Cytokine Signature in Cervical Fluids.
    J Infect Dis. 2016;213:723-30.
    PubMed     Text format     Abstract available


    February 2016
  15. PIERCE CAMPBELL CM, Viscidi RP, Torres BN, Lin HY, et al
    Human papillomavirus (HPV) L1 serum antibodies and risk of subsequent oral HPV acquisition in men: The HIM Study.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  16. D'SOUZA G, Wentz A, Kluz N, Zhang Y, et al
    Gender differences in risk factors and natural history of oral human papillomavirus (HPV) infection.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  17. CHESSON HW, Laprise JF, Brisson M, Markowitz LE, et al
    The Impact and Cost-Effectiveness of 3 doses of 9-Valent Human Papillomavirus (HPV) Vaccine among US Females Previously Vaccinated with 4-Valent HPV Vaccine.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  18. MEYS R, Purdie KJ, de Koning MN, Quint KD, et al
    HLA immunogenotype determines persistent HPV infection in anti-retroviral treated HIV.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  19. PUTHANAKIT T, Huang LM, Chiu CH, Tang RB, et al
    A randomised open trial comparing 2-dose regimens of the HPV-16/18 AS04-adjuvanted vaccine in girls aged 9-14 years versus 3 doses in women aged 15-25 years.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    January 2016
  20. RADZIO J, Henning T, Jenkins L, Ellis S, et al
    Combination emtricitabine and tenofovir disoproxil fumarate prevents vaginal SHIV infection in macaques harboring C. trachomatis and T. vaginalis.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    December 2015
  21. FIFE KH, Mugwanya K, Thomas KK, Baeten JM, et al
    Transient Increase in HSV-2-Associated Genital Ulcers Following Initiation of Antiretroviral Therapy in HIV-1/HSV-2 Co-Infected Individuals.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  22. BEACHLER DC, Jenkins G, Safaeian M, Kreimer AR, et al
    Natural acquired immunity against subsequent genital HPV infection: a systematic review and meta-analysis.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  23. HEARD I, Poizot-Martin I, Potard V, Etienney I, et al
    Prevalence of and risk factors for Anal Oncogenic human papillomavirus infection among HIV-Infected Women in France in the cART era.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  24. SCHILLER JT, Lowy DR
    Reply to Nalin.
    J Infect Dis. 2015;212:2021-2.
    PubMed     Text format    


  25. MARRA CM, Tantalo LC, Sahi SK, Dunaway SB, et al
    Treponema pallidum-specific Opsonic Antibody Activity is Reduced in HIV-Infected Patients with Syphilis.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


    November 2015
  26. GRABOWSKI MK, Kong X, Gray RH, Serwadda D, et al
    Partner human papillomavirus viral load and incident human papillomavirus detection in heterosexual couples.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


    October 2015
  27. HARARI A, Chen Z, Rodriguez AC, Hildesheim A, et al
    Cross-protection of the bivalent human papillomavirus (HPV) vaccine against variants of genetically related high-risk HPV infections.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  28. GRAD YH, Goldstein E, Lipsitch M, White PJ, et al
    Improving control of antibiotic resistant gonorrhea by integrating research agendas across disciplines: key questions arising from mathematical modeling.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  29. PHIPPS W, Nakku-Joloba E, Krantz EM, Selke S, et al
    Genital Herpes Simplex Virus Type 2 Shedding Among Adults With and Without HIV Infection in Uganda.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  30. LOW AJ, Nagot N, Weiss HA, Konate I, et al
    Herpes simplex virus type-2 (HSV-2) cervico-vaginal shedding among women living with HIV-1 on antiretroviral therapy in Burkina Faso: an 8-year longitudinal study.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


    September 2015
  31. RUSSELL AN, Zheng X, O'Connell CM, Taylor BD, et al
    Analysis of factors driving incident and ascending infection and the role of serum antibody in Chlamydia trachomatis genital tract infection.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


    August 2015
  32. GRAVITT PE
    HPV Seroprevalence in the United States: Behavior, Biology, and Prevention.
    J Infect Dis. 2015.
    PubMed     Text format    


  33. LIU G, Markowitz LE, Hariri S, Panicker G, et al
    Seroprevalence of 9 Human Papillomavirus Types in the United States, 2005-2006.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  34. NALIN DR
    Single-Dose Vaccines.
    J Infect Dis. 2015.
    PubMed     Text format    


  35. CONLEY LJ, Bush TJ, Darragh TM, Palefsky JM, et al
    Incidence and Predictors For Development of Abnormal Anal Cytology Among HIV-infected Adults Receiving Contemporary Antiretroviral Therapy.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


    July 2015
  36. ELFSTROM KM, Lazzarato F, Franceschi S, Dillner J, et al
    Human papillomavirus vaccination of boys and extended catch-up vaccination: Effects on the resilience of programs.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


    June 2015
  37. DUNNE EF, Naleway A, Smith N, Crane B, et al
    Reduction in HPV vaccine type prevalence among young women screened for cervical cancer in an integrated health care delivery system, United States 2007, 2012-2013.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  38. MANAM S, Thomas JD, Li W, Maladore A, et al
    Tumor Necrosis Factor (TNF) Receptor Superfamily Member 1b on CD8+ T Cells and TNF Receptor Superfamily Member 1a on Non-CD8+ T Cells Contribute Significantly to Upper Genital Tract Pathology Following Chlamydial Infection.
    J Infect Dis. 2015;211:2014-22.
    PubMed     Text format     Abstract available


  39. BENDER IGNACIO RA, Perti T, Magaret AS, Rajagopal S, et al
    Oral and gel tenofovir for genital HSV-2 shedding in immunocompetent women: a double-blind randomized cross-over trial (128/160 chars&spaces).
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


    May 2015
  40. BEACHLER DC, Guo Y, Xiao W, Burk RD, et al
    High oral HPV16 viral load predicts long-term persistence in HIV-infected and at risk HIV-uninfected individuals.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  41. GRABOWSKI MK, Kigozi G, Gray RH, Armour B, et al
    HSV-2 shedding from male circumcision wounds in Rakai, Uganda.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  42. HAMPRAS SS, Giuliano AR, Lin HY, Fisher KJ, et al
    Natural history of polyomaviruses in men: the HPV infection in men (HIM) study.
    J Infect Dis. 2015;211:1437-46.
    PubMed     Text format     Abstract available


    March 2015
  43. OLSEN AW, Follmann F, Erneholm K, Rosenkrands I, et al
    Vaccine promoted neutralizing antibodies directed to the VD4 of MOMP protect against Chlamydia trachomatis infection and upper genital tract pathology.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  44. GIANELLA S, Redd AD, Grabowski MK, Tobian AA, et al
    Vaginal Cytomegalovirus Shedding before and after Initiation of Antiretroviral Therapy in Rakai, Uganda.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  45. SENKOMAGO V, Backes DM, Hudgens MG, Poole C, et al
    Acquisition and persistence of human papillomavirus 16 (HPV-16) and HPV-18 among men with high-HPV viral load infections in a circumcision trial in Kisumu, Kenya.
    J Infect Dis. 2015;211:811-20.
    PubMed     Text format     Abstract available


    February 2015
  46. MULLER K, Kazimiroff J, Fatahzadeh M, Smith RV, et al
    Oral Human Papillomavirus and Oral Lesions In HIV-positive and HIV-negative Dental Patients.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  47. NYITRAY AG, Chang M, Villa LL, Carvalho da Silva RJ, et al
    The natural history of genital human papillomavirus among HIV-negative men having sex with men and men having sex with women.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


    January 2015
  48. GULATI S, Mu X, Zheng B, Reed GW, et al
    Antibody to reduction modifiable protein (Rmp) increases the bacterial burden and the duration of gonococcal infection in a mouse model.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  49. ESBER A, Vicetti Miguel RD, Cherpes TL, Klebanoff M, et al
    Risk of bacterial vaginosis among women with herpes simplex virus type 2 infection: a systematic review and meta-analysis.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


    December 2014
  50. VODSTRCIL LA, McIver R, Huston WM, Tabrizi SN, et al
    The epidemiology of organism load in genital Chlamydia trachomatis infection - a systematic review.
    J Infect Dis. 2014.
    PubMed     Text format     Abstract available


  51. GOMEZ GB, Ward H, Garnett GP
    Risk pathways for gonorrhea acquisition in sex workers: can we distinguish confounding from an exposure effect using a priori hypotheses?
    J Infect Dis. 2014;210 Suppl 2:S579-85.
    PubMed     Text format     Abstract available


  52. DAVIES B, Ward H, Leung S, Turner KM, et al
    Heterogeneity in risk of pelvic inflammatory diseases after Chlamydia infection: a population-based study in manitoba, Canada.
    J Infect Dis. 2014;210 Suppl 2:S549-55.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Sexually Transmitted Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: